Novel phage lysin Abp013 against Acinetobacter baumannii
As antimicrobial resistance (AMR) continues to pose an ever-growing global health threat, propelling us into a post-antibiotic era, novel alternative therapeutic agents are urgently required. Lysins are bacteriophage-encoded peptidoglycan hydrolases that display great potential as a novel class of a...
Main Authors: | Chu, Joash Jun Keat, Poh, Wee Han, Nabilah Taqiah Hasnuddin, Hew, En Yi, Dam, Linh Chi, El Sahili, Abbas, Rice, Scott A., Goh, Boon Chong |
---|---|
Other Authors: | School of Biological Sciences |
Format: | Journal Article |
Language: | English |
Published: |
2022
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/160715 |
Similar Items
-
Novel Phage Lysin Abp013 against <i>Acinetobacter baumannii</i>
by: Joash Jun Keat Chu, et al.
Published: (2022-01-01) -
Enhanced antibacterial activity of Acinetobacter baumannii bacteriophage ØABP-01 endolysin (LysABP-01) in combination with colistin
by: Rapee Thummeepak, et al.
Published: (2016-09-01) -
Antimicrobial activity of LysSS, a novel phage endolysin, against Acinetobacter baumannii and Pseudomonas aeruginosa
by: Shukho Kim, et al.
Published: (2020-09-01) -
Phage Lysins for Fighting Bacterial Respiratory Infections: A New Generation of Antimicrobials
by: Roberto Vázquez, et al.
Published: (2018-10-01) -
Engineered Lysins With Customized Lytic Activities Against Enterococci and Staphylococci
by: Hana Sakina Binte Muhammad Jai, et al.
Published: (2020-11-01)